Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial

被引:0
作者
Kwai Han Yoo
Hyewon Lee
Cheolwon Suh
机构
[1] Gachon University Gil Medical Center,Division of Hematology, Department of Internal Medicine
[2] National Cancer Center,Center for Hematologic Malignancy
[3] University of Ulsan College of Medicine,Department of Oncology, Asan Medical Center
来源
International Journal of Hematology | 2018年 / 107卷
关键词
Lymphoma; Korea; Epidemiology; Clinical trial;
D O I
暂无
中图分类号
学科分类号
摘要
Lymphomas are a heterogeneous group of disease entities with well-defined clinical, morphological, immunophenotypic, and cytogenetic characteristics. Moreover, regional and racial differences have been reported in their incidence and subtype compositions. Here, we reviewed the epidemiology of lymphomas and summarized the recent achievements in specific subtypes prevalent in Korean population, focusing on clinical studies conducted by the Consortium for Improving Survival of Lymphoma (CISL) of the Korean Society of Hematology Lymphoma Working Party (KSH-LWP).
引用
收藏
页码:395 / 404
页数:9
相关论文
共 366 条
  • [1] Harris NL(1994)A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 1361-1392
  • [2] Jaffe ES(2011)The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications Blood 117 5019-5032
  • [3] Stein H(2016)The 2016 revision of the World Health Organization classification of lymphoid neoplasms Blood 127 2375-2390
  • [4] Banks PM(2012)Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008 Korean J Hematol 47 28-38
  • [5] Chan JK(2012)Epidemiologic overview of malignant lymphoma Korean J Hematol 47 92-104
  • [6] Cleary ML(2017)Health disparities and the global landscape of lymphoma care today Am Soc Clin Oncol Educ Book 37 526-534
  • [7] Campo E(2005)Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology Ann Hematol 84 1-12
  • [8] Swerdlow SH(2014)Differences in incidence and trends of haematological malignancies in Japan and the United States Br J Haematol 164 536-545
  • [9] Harris NL(2016)Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001–2010 Cancer Epidemiol 42 15-23
  • [10] Pileri S(1998)Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index Nihon Koshu Eisei Zasshi 45 1011-1017